siRNA, Anti-Human APOA2, LNA(CAT#: SIRGT04223WQ-LNA)

The product SIRGT04223WQ-LNA is a type of small interfering RNA (siRNA) that targets APOA2 gene and regulates the expression of gene. The siRNA interferes with the expression of APOA2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001643.1
Alternative Names Apo-AII; ApoA-II; apoAII
Related Diseases Apolipoprotein A-II deficiency, Hypercholesterolemia
Purification HPLC
Target Gene
Gene ID 336
Uniprot ID P02652

Related Products